Key result
SGLT2 inhibitors are linked to higher AF remission post-ablation, while higher HbA1c raises recurrence risk.
Why the study?
The prognostic value of electrolyte imbalances, glycemic control, echocardiography parameters, and medical therapy for early and late atrial fibrillation recurrences after radiofrequency catheter ablation in patients with type 2 diabetes mellitus required evaluation.
Do baseline serum electrolyte imbalances, glycemic control (HbA1c), and SGLT2 inhibitor therapy predict atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus undergoing radiofrequency catheter ablation?
Cohort (n=60)
No
Do baseline serum electrolyte imbalances, glycemic control (HbA1c), and SGLT2 inhibitor therapy predict atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus undergoing radiofrequency catheter ablation?
In patients with type 2 diabetes mellitus undergoing radiofrequency catheter ablation for atrial fibrillation, routine baseline serum electrolytes do not independently predict long-term recurrence, whereas SGLT2 inhibitor use and optimal glycemic control (lower HbA1c) are strongly associated with maintaining sinus rhythm.
Answers are grounded in this paper and cite their sources.
SGLT2 inhibitor use may aid AF remission after ablation in T2DM; leaves open confirmation in randomized trials.
Aim. To evaluate the relationship between electrolyte parameters (including serum potassium, magnesium, sodium, and calcium levels), instrumental data (echocardiography), received therapy, and the frequency of early and late recurrences of atrial fibrillation in patients with type 2 diabetes mellitus after radiofrequency ablation. To determine the prognostic value of electrolyte imbalances and glycemic control as potential modifiable risk factors for the failure of interventional treatment. Materials and methods. A retrospective analysis of medical histories of patients who were hospitalized in the cardiology department of Endocrinology Research Centre from 1st January 2017 to 30th October 2025 was conducted. Results. No statistically significant differences between the groups were found in the levels of potassium, sodium, chlorides, and magnesium. The mean total calcium level in both groups was 2.4 mmol/L (p=0.032), with a larger standard deviation observed in the recurrence group. The use of sodium-glucose cotransporter-2 inhibitors was associated with a higher remission rate (67% vs 23%; p=0.005). Glycated hemoglobin (HbA1c) levels were comparable (6.6 and 7.3% respectively). Conclusion. Routinely measured electrolyte disturbances within the range typical for most patients are not independent predictors of long-term recurrences of atrial fibrillation after radiofrequency catheter ablation. Well-controlled type 2 diabetes mellitus (glycated hemoglobin 7%) and therapy with sodium-glucose cotransporter-2 inhibitors are associated with a reduced recurrence rate. Prospective studies are needed to clarify the role of calcium and dynamic electrolyte monitoring.
No takes yet. Share an insight, caveat, or question.
Мясникова et al. (2026) conducted a cohort in Paroxysmal atrial fibrillation and type 2 diabetes mellitus undergoing radiofrequency catheter ablation (n=60). Absence of SGLT2 inhibitor therapy, glycemic control (HbA1c), and serum electrolyte levels vs. SGLT2 inhibitor therapy and normal glycemic/electrolyte parameters was evaluated on Atrial fibrillation recurrence following radiofrequency catheter ablation (associated with absence of SGLT2 inhibitor therapy) (OR 52.612, 95% CI 2.794-990.760, p=0.005). SGLT2 inhibitor therapy was associated with higher AF remission after ablation, while each 1% HbA1c increase raised recurrence odds.
Synapse has enriched 10 related papers. Consider them for comparative context: